Gut microbiota and intestinal mucosa (No canonical abbreviation for the paired system.)

The gut microbiota and intestinal mucosa represent the dynamic interface between microbial communities inhabiting the human GI tract and the host’s mucus-coated epithelial barrier. The intestinal mucosa is covered by a dense layer of mucus, primarily composed of heavily glycosylated mucin proteins (notably MUC2), which provides a segregating physical and chemical barrier preventing microbial translocation into underlying tissues. Microbial species in the gut, including bacteria from the Bacteroidetes and Firmicutes phyla, interact with this mucus layer, using it both as a substrate for energy and as a niche for colonization. The mucosal immune system and microbial signals tightly regulate each other, maintaining local and systemic immune homeostasis. Breakdown of this interface due to dietary or genetic factors can lead to inflammation, infection, and chronic disease. Therapeutic interventions typically target components of this system rather than the whole, with ongoing research into microbiota-directed drugs and personalized nutrition.

Other names

Gastrointestinal microbiome and mucosal barrierGut flora and intestinal mucus layerGut-microbiota/mucosa interface

Probiotics: restoration of beneficial species or competitive exclusion of pathogens Prebiotics: support growth of commensals and impact mucosal glycosylation Antibiotics: depletion/disruption of microbial populations Immunomodulators: reduction of mucosal inflammation